Viewing Study NCT00596804


Ignite Creation Date: 2025-12-24 @ 7:54 PM
Ignite Modification Date: 2026-01-06 @ 6:32 AM
Study NCT ID: NCT00596804
Status: COMPLETED
Last Update Posted: 2021-08-18
First Post: 2008-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module